4/30
08:48 am
thar
Tharimmune To Participate in Two Upcoming Investor Conferences in May [Yahoo! Finance]
Low
Report
Tharimmune To Participate in Two Upcoming Investor Conferences in May [Yahoo! Finance]
4/30
08:31 am
thar
Tharimmune To Participate in Two Upcoming Investor Conferences in May
Medium
Report
Tharimmune To Participate in Two Upcoming Investor Conferences in May
4/23
07:49 am
thar
Tharimmune Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates (ADCs) [Yahoo! Finance]
Low
Report
Tharimmune Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates (ADCs) [Yahoo! Finance]
4/23
07:31 am
thar
Tharimmune Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates (ADCs)
Low
Report
Tharimmune Announces Option Agreement for Key Technologies for Generating HER2/HER3 Antibody Drug Conjugates (ADCs)
4/15
08:50 am
thar
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics [Yahoo! Finance]
Medium
Report
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics [Yahoo! Finance]
4/15
08:31 am
thar
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics
Medium
Report
Tharimmune Announces Scientific Advisory Board to Drive Clinical-Stage Lead in Chronic Liver Disease and Early-Stage Tunable Knob Domains for Generating Antibody Drug Conjugate (ADC) Biotherapeutics
3/6
07:12 am
thar
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now [Yahoo! Finance]
Medium
Report
Presenting on the Emerging Growth Conference 68 Day 2 on March 7 Register Now [Yahoo! Finance]
3/5
08:50 am
thar
Tharimmune to Present at the Emerging Growth Conference on March 7, 2024 [Yahoo! Finance]
Low
Report
Tharimmune to Present at the Emerging Growth Conference on March 7, 2024 [Yahoo! Finance]
3/5
08:31 am
thar
Tharimmune to Present at the Emerging Growth Conference on March 7, 2024
Low
Report
Tharimmune to Present at the Emerging Growth Conference on March 7, 2024
2/20
08:01 am
thar
Tharimmune Announces Positive Results in Phase 1 Clinical Trial of TH104, its Lead Clinical Therapeutic Candidate
Medium
Report
Tharimmune Announces Positive Results in Phase 1 Clinical Trial of TH104, its Lead Clinical Therapeutic Candidate
2/5
08:30 am
thar
Tharimmune Announces Dosing of First Patient in Phase 1 Clinical Trial of TH104, its Lead Candidate for Pruritus in Primary Biliary Cholangitis
Medium
Report
Tharimmune Announces Dosing of First Patient in Phase 1 Clinical Trial of TH104, its Lead Candidate for Pruritus in Primary Biliary Cholangitis